The PAAG regimen significantly improved PFS and response rates in metastatic pancreatic cancer compared to chemotherapy alone ...
News-Medical.Net on MSN
Durvalumab extends survival in small cell lung cancer but raises cost concerns
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
Inovio’s upside hinges on INO-3107 for HPV-6/11 RRP with FDA PDUFA Oct 2026, regulatory risk, tight cash, and cheap EV. Check ...
No IPOs are currently scheduled in the week ahead, although smaller issuers may join the calendar throughout the week. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback